Health product recall

Heparin Sodium and 0.9% Sodium Chloride Injection (2020-01-31)

Starting date:
January 31, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-74263

Last updated: 2020-11-03

Summary

  • Product: Heparin Sodium and 0.9% Sodium Chloride Injection

Reason

The affected lot was inadvertently distributed to the market.

Depth of distribution

Healthcare establishments

Affected products

Heparin Sodium and 0.9% Sodium Chloride Injection

DIN, NPN, DIN-HIM

DIN 00828750

Dosage form

Solution

Strength

Heparin (Heparin Sodium) 2 UNIT / ML
Sodium Chloride 9 MG / ML

Lot or serial number

W9J03B1

Companies

Recalling Firm
Baxter Corporation
7125 Mississauga Road
Mississauga
L5N 0C2
Ontario
CANADA
Marketing Authorization Holder
Baxter Corporation
7125 Mississauga Road
Mississauga
L5N 0C2
Ontario
CANADA

Date modified: